内部人交易记录
其他尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the complete record of transactions filed by Farag Kameel D.. Director active across 1 company, notably Akari Therapeutics Plc. In total, 12 reports have been logged. History available since 22 October 2025. The latest transaction was filed on 17 August 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Farag Kameel D.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报12 总计
1,728 股@ US$7.52American Depositary Shares representing Ordinary SharesSEC:0001493152-26-039246:0
1,130 股@ US$11.500.095% mcap21.2% 占其流量American Depositary Shares representing Ordinary SharesSEC:0001493152-26-036231:0
1,248 股American Depositary Shares representing Ordinary SharesSEC:0001493152-26-030210:0
1,395 股American Depositary Shares representing Ordinary SharesSEC:0001493152-26-030210:1
1,570 股American Depositary Shares representing Ordinary SharesSEC:0001493152-26-030210:2
2,539 股American Depositary Shares representing Ordinary SharesSEC:0001493152-26-030210:3
3,725 股American Depositary Shares representing Ordinary SharesSEC:0001493152-26-030210:4
7,353 股American Depositary Shares representing Ordinary SharesSEC:0001493152-26-030210:5
1,000 股American Depositary Shares representing Ordinary SharesSEC:0001493152-26-030210:6
32,000 股@ US$0.7554.6% 占其流量American Depositary Shares representing Ordinary SharesSEC:0001493152-25-020753:0
26,619 股@ US$0.7545.4% 占其流量American Depositary Shares representing Ordinary SharesSEC:0001493152-25-020753:1
6,277 股@ US$0.749.5% 占其流量American Depositary Shares representing Ordinary SharesSEC:0001493152-25-019194:0
About Farag Kameel D.
Farag Kameel D. is a declarant linked to Akari Therapeutics Plc, where the listed role is Interim CFO. The record shows 11 filings, and the sampled recent filings cover the period from 2025-10-24 to 2026-08-05, with a modal transaction nature of Attribution.